Bruker Announces Acquisition of SkyScan
News Apr 09, 2012
Bruker Corporation has announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed.
For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
SkyScan's revenue is derived approximately 50% from materials science and 50% from life science and preclinical imaging applications.
SkyScan develops, manufactures and distributes worldwide advanced, high-resolution micro computed tomography (CT) systems for three-dimensional (3D) X-ray imaging.
SkyScan's micro-CT instruments can be configured for numerous applications in materials research and in the life sciences, including in vivo preclinical animal imaging, in vitro bone and soft tissue imaging, 3D imaging of electronic components, synthetic materials, new devices such as microsensors and cardio-stimulators, geological samples, fuel cell components, ceramics, and more.
Following the acquisition, the company has been renamed Bruker microCT N.V., and will continue to operate from the company-owned premises in Belgium under its previous management.
The new Bruker microCT business will continue to produce all micro-CT instruments under the SkyScan brand, and will provide enhanced global support for the installed worldwide base of SkyScan.
With global Bruker distribution and customer service capabilities for materials research, preclinical imaging, and SEM accessories, the Bruker microCT business is now well positioned to drive the further profitable growth of the SkyScan 3D micro-CT imaging products.
In addition, most successful SkyScan distributors will be able to continue to distribute SkyScan products in their countries or market segments.
Bruker intends to invest in additional micro-CT applications and demo centers to further enhance customer collaborations and support worldwide.
Dr. Alexander Sasov, founder and CEO of the former SkyScan company, and now Managing Director and CEO of Bruker microCT, commented: "We have been looking for a strong and competent strategic partner to continue the rapid growth that SkyScan has enjoyed over many years. I am very glad that with the strong Bruker brand and the additional worldwide Bruker distribution channels and support network, we have found exactly what we were looking for to drive our micro-CT business to the next level of success."
Frank Laukien, PhD, President and CEO of Bruker Corporation, added: "We are excited to have Alexander Sasov and his capable SkyScan team join us, adding in-depth 3D X-ray micro-CT imaging experience to Bruker. We are impressed by the portfolio of high-performance SkyScan products which fit nicely into our global materials research and preclinical imaging distribution channels, and which complement our other X-ray analysis and preclinical MRI products. The Bruker microCT team shares our philosophy of innovation, quality and customer support excellence."
Chemical Imaging Reveals Details of Ancient ArtworkNews
Scientists have used a combination of three advanced imaging techniques to produce a highly detailed analysis of a second century Egyptian painting. They are the first to use the specific combination — which they termed “macroscale multimodal chemical imaging” — to examine an ancient work of art.READ MORE
Hyperlens Crystal Capable of Viewing Living Cells in Unprecedented DetailNews
Just imagine: An optical lens so powerful that it lets you view features the size of a small virus on the surface of a living cell in its natural environment. Fundamental advances in the quality of an optical material used in hyperlensing, a method of creating lenses that can resolve objects much smaller than the wavelength of light, now makes this possible.READ MORE
Visualizing Single Molecules in Whole Cells with a New SpinNews
Researchers have adapted DNA-PAINT technology to confocal microscopes, and demonstrated that the method can visualize a variety of different molecules, including combinations of different proteins, RNAs, and DNA throughout the entire depth of whole cells at super-resolution.READ MORE